Gastrointestinal Bleeding Treatment Market 2024-2028: Size and High treatment costs; growth driven by the Product, Some of key Companies Positioned Strategically

The gastrointestinal bleeding treatment market size by Product (Endoscopic mechanical devices, Endoscopic thermal devices, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 182.6 million. The market is expected to grow at a CAGR of   4.5% between 2024 and 2028.

• The global gastrointestinal bleeding treatment market is experiencing significant growth, driven by the increasing prevalence of gastrointestinal disorders and the rising demand for effective diagnostic and therapeutic solutions. However, the market growth is being challenged by the high costs associated with advanced diagnostic and treatment devices, particularly endoscopic kits. In price-sensitive markets, such as developing and emerging economies, the affordability of these capital-intensive items remains a major barrier. Even in developed countries, smaller hospitals and private physician clinics may defer purchases due to budget constraints. Procurement of endoscopic devices involves complex budgeting procedures and considerations, and the ongoing maintenance costs further add to the financial burden for end-users.
• The gastrointestinal bleeding treatment market represents a significant business opportunity due to the rising prevalence of gastrointestinal disorders and an increasing awareness of their symptoms. Key players in this market focus on developing innovative solutions, such as endoscopic therapies and hemorrhage control agents, to address the unmet medical needs of patients experiencing gastrointestinal bleeding. Market growth is further driven by advancements in diagnostic technologies and a growing geriatric population, who are more susceptible to gastrointestinal disorders.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Boston Scientific Corp.
• Conmed Corp.
• Cook Group Inc.
• EndoClot Plus Inc.
• Erbe Elektromedizin GmbH
• Mayo Foundation for Medical Education and Research
• Medtronic Plc
• Olympus Corp.
• Ovesco Endoscopy AG
• STERIS plc
• University Hospitals

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/